Top

Published in:

Open Access 01-12-2022 | Obesity | Research

Cardiometabolic profile of 15057 elderly Spanish workers: association of sociodemographic variables and tobacco consumption

Authors: J. I. Ramírez-Manent, B. Altisench Jané, S. Arroyo Bote, C. López Roig, H. González San Miguel, A. A. López-González

Published in: BMC Geriatrics | Issue 1/2022

Abstract

Background

Aging of the world population is one of the most significant demographic changes of our time. Populations older than 60 years are heterogeneous, and age is an independent cardiovascular risk factor aggravated by frailty, obesity, and diabetes, and influenced by several factors, including sex and socioeconomic status. The objective of this study was to calculate cardiovascular risk in workers of both sexes over 60 years of age and to assess whether there are difference s by sex, social class, smoking, and type of job.

Methods

A cross-sectional study was carried out in 15,057 elderly Spanish workers from different autonomous communities in Spain and with different labor occupations. Anthropometric, sociodemographic, clinical, and laboratory values were determined. People were classified according to age from 60 to 64 years inclusive and from 65 to 69 years, smokers and non-smokers, and both blue-collar and white-collar workers. Subsequently, a multivariate analysis was carried out.

Results

Men, blue-collar workers, smokers, and aging were factors that influenced cardiovascular risk: with an OR of 3.27 (95% CI: 2.64–4.05) in people 65 years of age or older versus the younger group, and an OR of 3.15 (95% CI: 2.69–3.69) in smokers versus non-smokers. A stronger independent association was found between smoking, age, and cardiovascular risk. The risk of developing non-alcoholic fatty liver and liver fibrosis was much higher in men than in women, with an OR of 4.06 (95% CI: 3.66–4.50) for the former and an OR of 2.10 (95% CI: 1.95–2.26) for the BARD index.

Conclusions

The highest risk groups were observed in male subjects with a history of smoking and blue-collar workers and, as such, should be considered for cardiovascular risk screening programs.

Naciones Unidas. En Asuntos DoEaS, ed. Envejecimiento de la Población y Desarrollo. Nueva York: Naciones Unidas; 2012.

Veronese N, Koyanagi A, Smith L, Musacchio C, Cammalleri L, Barbagallo M, et al. Multidimensional frailty increases cardiovascular risk in older people: an 8-year longitudinal cohort study in the osteoarthritis initiative. Exp Gerontol. 2021;147:111265. https://doi.org/10.1016/j.exger.2021.111265 Epub 2021 Feb 1.CrossRefPubMed

Gorostidi M, Sánchez-Martínez M, Ruilope LM, Graciani A, de la Cruz JJ, et al. Chronic kidney disease in Spain: prevalence and impact of accumulation of cardiovascular risk factors. Nefrologia (Engl Ed). 2018;38(6):606–15. https://doi.org/10.1016/j.nefro.2018.04.004 Epub 2018 Jun 18.CrossRef

Kulmala J, Nykanen I, Hartikainen S. Frailty as a predictor of all-cause mortality in older men and women. Geriatr Gerontol Int. 2014;14:899–905. https://doi.org/10.1111/ggi.12190.CrossRefPubMed

Yazdanyar A, Newman AB. The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs. Clin Geriatr Med. 2009;25:563–77. https://doi.org/10.1016/j.cger.2009.07.007.CrossRefPubMedPubMedCentral

https://www.sanidad.gob.es/estadEstudios/estadisticas/sisInfSanSNS/tablasEstadisticas/InfAnualSNS2020_21/INFORME_ANUAL_2020_21.pdf. Access 2 September 2022.

Marí-Dell'olmo M, Gotsens M, Borrell C, Martinez-Beneito MA, Palència L, et al. Trends in socioeconomic inequalities in ischemic heart disease mortality in small areas of nine Spanish cities from 1996 to 2007 using smoothed ANOVA. J Urban Health. 2014;91(1):46–61. https://doi.org/10.1007/s11524-013-9799-6.CrossRefPubMed

Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke Statistics-2019 update: a report from the American Heart Association. Circulation. 2019. https://doi.org/10.1161/CIR.0000000000000659.

Schreuder MM, Boersma E, Kavousi M, Visser LE, Roos-Hesselink JW, et al. Reporting of sex-specific outcomes in trials of interventions for cardiovascular disease: has there been progress? Maturitas. 2021;144:1–3. https://doi.org/10.1016/j.maturitas.2020.09.007 Epub 2020 Sep 28.CrossRefPubMed

10.

World Health Organization. 65th world health assembly closes with new global health measures: World Health Organization. https://apps.who.int/mediacentre/news/releases/2012/wha65_closes_20120526/es/index.html.Access 5 March 2022

11.

Stewart A, Marfell-Jones M, Olds T, Ridder H. International standards for anthropometric assessment. Lower Hutt, New Zealand: International Society for the Advancement of Kinanthropometry - ISAK0; 2011.

12.

Sedeño Argilagos C, González San Miguel HM, Martínez-Sánchez G, Pérez-Davison G, Rigo Vives MM. Determination of different scales of cardiovascular risk in 1.979 spanish informatics workers. Med Balear (Academic Journal of Health Sciences). 2022;37(2):33–41. https://doi.org/10.3306/AJHS.2022.37.02.33.CrossRef

13.

Reyes-Barrera J, Sainz-Escárrega VH, Medina-Urritia AX, Jorge-Galarza E, Osorio-Alonso H, Torres-Tamayo M, et al. Dysfunctional adiposity index as a useful clinical tool for early identification of adipose tissue Morpho-functional abnormalities and Cardiometabolic disorders in apparently healthy subjects. Res Square. 2020; Available at: https://www.researchsquare.com/article/rs-97962/v1.

14.

Andrade MD, Freitas MC, Sakumoto AM, Pappiani C, Andrade SC, Vieira VL, et al. Association of the conicity index with diabetes and hypertension in Brazilian women. Arch Endocrinol Metab. 2016;60(5):436–42.CrossRefPubMed

15.

López-González AA, Ramírez Manent JI, Vicente-Herrero MT, García Ruiz E, Albaladejo Blanco M, López SN. Prevalence of diabesity in the Spanish working population: influence of sociodemographic variables and tobacco consumption. An Sist Sanit Navar. 2021;0(0). https://doi.org/10.23938/ASSN.0977.

16.

Rangel-Baltazar E, Cuevas-Nasu L, Shamah-Levy T, Rodríguez-Ramírez S, Méndez-Gómez-Humarán I, Rivera JA. Association between high waist-to-height ratio and cardiovascular risk among adults sampled by the 2016 half-way National Health and nutrition survey in Mexico (ENSANUT MC 2016). Nutrients. 2019;11(6):1402. https://doi.org/10.3390/nu11061402.CrossRefPubMedCentral

17.

López González ÁA, Rivero Ledo YI, Vicente Herrero MT, Gil Llinás M, Tomás Salvá M, Riutord FB. Índices aterogénicos en trabajadores de diferentes sectores laborales del área mediterránea española. Clin Investig Arterioscler. 2015;27(3):118–28.PubMed

18.

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97. https://doi.org/10.1001/jama.285.19.2486.

19.

Zimmet P, MM Alberti KG, Serrano Ríos M. A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results. Rev Esp Cardiol. 2005;58(12):1371–6.CrossRefPubMed

20.

Cabrera-Roe E, Stusser B, Cálix W, Orlandi N, Rodríguez J, Cubas-Dueñas I, et al. Concordancia diagnóstica entre siete definiciones de síndrome metabólico en adultos con sobrepeso y obesidad. Rev Peru Med Exp Salud Publica. 2017;34(1):19–27.CrossRef

21.

Marrugat J, Subirana I, Comín E, Cabezas C, Vila J, Elosua R, et al. Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA study. J Epidemiol Community Health. 2007;61:40–7.CrossRefPubMedPubMedCentral

22.

Marrugat J, D’Agostino R, Sullivan L, Elosua R, Wilson P, Ordovas J, et al. An adaptation of the Framingham coronary risk function to southern Europe Mediterranean areas. J Epidemiol Community Health. 2003;57(8):634–8.CrossRefPubMedPubMedCentral

23.

Sans S, Fitzgerald AP, Royo D, Conroy R, Graham I. Calibrating the SCORE cardiovascular risk chart for use in Spain. Rev Esp Cardiol. 2007;60(5):476–85.CrossRefPubMed

24.

Buitrago F, Cañón Barroso L, Díaz Herrera N, Cruces E. Analysis of predictive value of Framingham-REGICOR and SCORE functions in primary health care. Med Clin (Barc). 2007;129(20):797.CrossRef

25.

Cuende JL. La edad vascular frente al riesgo cardiovascular: aclarando conceptos. Rev Esp Cardiol. 2016;69(3):243–6.CrossRefPubMed

26.

Cuende JI. Edad vascular, RR, ALLY, RALLY y velocidad de envejecimiento, basados en el SCORE: relaciones entre nuevos conceptos de prevención cardiovascular. Rev Esp Cardiol. 2018;71:399–400.CrossRefPubMed

27.

Sam S, Haffner S, Davidson MH, D'Agostino RB, Feinstein S, Kondos G, et al. Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes. Diabetes Care. 2009;32(10):1916–20.CrossRefPubMedPubMedCentral

28.

Yang RF, Liu XY, Lin Z, Zhang G. Correlation study on waist circumference-triglyceride (WT) index and coronary artery scores in patients with coronary heart disease. Eur Rev Med Pharmacol Sci. 2015;19(1):113–8.PubMed

29.

Wakabayashi I, Daimon T. The "cardiometabolic index" as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus. ClinChim Acta. 2015;438:274–8.CrossRef

30.

Unger G, Benozzi SF, Peruzza F, Pennacchiotti GL. Triglycerides and glucose index: a useful indicator of insulin resistance. Endocrinol Nutr. 2014;61(10):533–40.CrossRefPubMed

31.

Zheng S, Shi S, Ren X, Han T, Li Y, Chen Y, et al. Triglyceride glucose-waist circumference, a novel and effective predictor of diabetes in first-degree relatives of type 2 diabetes patients: cross-sectional and prospective cohort study. J Transl Med. 2016;14(1):260.CrossRefPubMedPubMedCentral

32.

Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.CrossRefPubMedPubMedCentral

33.

Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42(7):503–8.CrossRefPubMed

34.

Wang J, Xu C, Xun Y, Lu Z, Shi J, Yu C, et al. ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population. Sci Rep. 2015;5:16494.CrossRefPubMedPubMedCentral

35.

Fuyan S, Jing L, Wenjun C, Zhijun T, Weijing M, Suzhen W, et al. Fatty liver disease index: a simple screening tool to facilitate diagnosis of nonalcoholic fatty liver disease in the Chinese population. Dig Dis Sci. 2013;58(11):3326–34.CrossRefPubMed

36.

Chiang JK, Koo M. Lipid accumulation product: a simple and accurate index for predicting metabolic syndrome in Taiwanese people aged 50 and over. BMC Cardiovasc Disord. 2012;12:78.CrossRefPubMedPubMedCentral

37.

Bestehorn K, Smolka W, Pittrow D, Schulte H, Assmann G. Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory care. Curr Med Res Opin. 2010;26(12):2833–9.CrossRefPubMed

38.

Sun W, Cui H, Li N, Wei Y, Lai S, Yang Y, et al. Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease: a meta-analysis study. Hepatol Res. 2016;46(9):862–70. https://doi.org/10.1111/hepr.12647 Epub 2016 Feb 16.CrossRefPubMed

39.

Domingo-Salvany A, Bacigalupe A, Carrasco JM, Espelt A, Ferrando J, Borrell C. Propuesta de clase social neoweberiana y neomarxista a partir de la Clasificación Nacional de Ocupaciones 2011. Gac Sanit. 2013;27(3):263–72.CrossRefPubMed

40.

Yoon JL, Cho JJ, Park KM, Noh HM, Park YS. Diagnostic performance of body mass index using the Western Pacific regional Office of World Health Organization reference standards for body fat percentage. J Korean Med Sci. 2015;30(2):162–6. https://doi.org/10.3346/jkms.2015.30.2.162 Epub 2015 Jan 21.CrossRefPubMedPubMedCentral

41.

Okorodudu DO, Jumean MF, Montori VM, Romero-Corral A, Somers VK, Erwin PJ, et al. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes. 2010;34(5):791–9. https://doi.org/10.1038/ijo.2010.5 Epub 2010 Feb 2.CrossRef

42.

Davila-Batista V, Molina AJ, Fernández-Villa T, Romaguera D, Pérez-Gómez B, et al. The relation of CUN-BAE index with body mass index and waist circumference in adults aged 50 to 85 years: the MCC-Spain study. Nutrients. 2020;12(4):996. https://doi.org/10.3390/nu12040996.CrossRefPubMedCentral

43.

Molina-Luque R, Yañez AM, Bennasar-Veny M, Romero-Saldaña M, Molina-Recio G, López-González ÁA. A comparison of equation Córdoba for estimation of body fat (ECORE-BF) with other prediction equations. Int J Environ Res Public Health. 2020;17(21):7940. https://doi.org/10.3390/ijerph17217940.CrossRefPubMedCentral

44.

Shasha Y, Guo X, Li GX, Yang H, Zheng L, Sun Y. Gender discrepancy in the predictive effect of metabolic syndrome and its components on newly onset cardiovascular disease in elderly from rural China. BMC Geriatr. 2021;21:505. https://doi.org/10.1186/s12877-021-02393-6.CrossRef

45.

Sergi G, Dianin M, Bertocco A, Zanforlini BM, Curreri C, Mazzochin M, et al. Gender differences in the impact of metabolic syndrome components on mortality in older people: a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2020;30(9):1452–64. https://doi.org/10.1016/j.numecd.2020.04.034 Epub 2020.CrossRefPubMed

46.

He X, Zhang W, Pang G, et al. Prevalence and clinical profile of metabolic syndrome in longevity: study from Guangxi Zhuang autonomous region. China BMC Geriatr. 2017;17:169. https://doi.org/10.1186/s12877-017-0536-y.CrossRefPubMed

47.

Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212–24. https://doi.org/10.1016/S0140-6736(20)32511-3 Epub 2021 Apr 21. PMID: 33894145.CrossRefPubMed

48.

Makri E, Goulas A, Polyzos SA. Epidemiology, pathogenesis, diagnosis and emerging treatment of nonalcoholic fatty liver disease. Arch Med Res. 2021;52(1):25–37. https://doi.org/10.1016/j.arcmed.2020.11.010 Epub 2020 Dec 14. PMID: 33334622.CrossRefPubMed

49.

Roberts SK, Majeed A, Glenister K, Magliano D, Lubel JS, Bourke L, et al. Prevalence of non-alcoholic fatty liver disease in regional Victoria: a prospective population-based study. Med J Aust. 2021;215(2):77–82. https://doi.org/10.5694/mja2.51096 Epub 2021 May 24.CrossRefPubMed

50.

European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388–402 Epub 2016 Apr 7. PubMed PMID: 27062661.CrossRef

51.

Younossi Z, Tacke F, Arrese M, Sharma BC, Mostafa I, Bugianesi E, et al. Global perspectives on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Hepatology. 2019;69(6):2672–82. https://doi.org/10.1002/hep.30251.CrossRefPubMed

52.

Ramírez M. La edad vascular como herramienta de comunicación del riesgo cardiovascular. Centro Integral para la Prevención de Enfermedades Crónicas. 2010. Disponible en: http://pp.centramerica.com/pp/bancofotos/267-2570.pdf.

53.

Appelman Y, van Rijn BB, Ten Haaf ME, Boersma E, Peters SA. Sex differences in cardiovascular risk factors and disease prevention. Atherosclerosis. 2015;241(1):211–8. https://doi.org/10.1016/j.atherosclerosis.2015.01.027 Epub 2015 Jan 28. PMID: 25670232.CrossRefPubMed

54.

Liang Y, Vetrano DL, Qiu C. Serum total cholesterol and risk of cardiovascular and non-cardiovascular mortality in old age: a population-based study. BMC Geriatr. 2017;17:294. https://doi.org/10.1186/s12877-017-0685-z.CrossRefPubMedPubMedCentral

55.

Gamboa Madeira S, Reis C, Paiva T, Moreira CS, Nogueira P, Roenneberg T. Social jetlag, a novel predictor for high cardiovascular risk in blue-collar workers following permanent atypical work schedules. J Sleep Res. 2021;30(6):e13380. https://doi.org/10.1111/jsr.13380 Epub 2021 May 4. PMID: 33942925.CrossRefPubMedPubMedCentral

56.

Wagstaff A. Poverty and health sector inequalities. Bull World Health Organ. 2002;80(2):97–105 PMID: 11953787; PMCID: PMC2567730.PubMedPubMedCentral

57.

Khambaty T, Schneiderman N, Llabre MM, Elfassy T, Moncrieft AE, Daviglus M, et al. Elucidating the multidimensionality of socioeconomic status in relation to metabolic syndrome in the Hispanic community health study/study of Latinos (HCHS/SOL). Int J Behav Med. 2020;27(2):188–99. https://doi.org/10.1007/s12529-020-09847-y PMID: 31933127; PMCID: PMC7375751.CrossRefPubMedPubMedCentral

58.

Prihartono NA, Fitriyani F, Riyadina W. Cardiovascular disease risk factors among blue and white-collar Workers in Indonesia. Acta Med Indones. 2018;50(2):96–103 PMID: 29950527.PubMed

59.

Pankova A, Kralikova E, Zvolska K, Stepankova L, Blaha M, Ovesna P, et al. Early weight gain after stopping smoking: a predictor of overall large weight gain? A single-site retrospective cohort study. BMJ Open. 2018;8(12):e023987. https://doi.org/10.1136/bmjopen-2018-023987.CrossRefPubMedPubMedCentral

60.

Gonçalves-Martins G, Gil-Sala D, Tello-Díaz C, Tenezaca-Sari X, Marrero C, Puig T, et al. Prevalence of peripheral arterial disease and associated vascular risk factors in 65-years-old people of northern Barcelona. J Clin Med. 2021;10(19):4467. https://doi.org/10.3390/jcm10194467 PMID: 34640483; PMCID: PMC8509737.CrossRefPubMedPubMedCentral

61.

Fa-Binefa M, Clará A, Pérez-Fernández S, Grau M, Dégano IR, Marti-Lluch R, et al. Early smoking-onset age and risk of cardiovascular disease and mortality. Prev Med. 2019;124:17–22. https://doi.org/10.1016/j.ypmed.2019.04.022 Epub 2019 May 2. PMID: 31054906.CrossRefPubMed

Title: Cardiometabolic profile of 15057 elderly Spanish workers: association of sociodemographic variables and tobacco consumption
Authors: J. I. Ramírez-Manent
B. Altisench Jané
S. Arroyo Bote
C. López Roig
H. González San Miguel
A. A. López-González
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Obesity
Obesity
Fatty Liver
Published in: BMC Geriatrics / Issue 1/2022
Electronic ISSN: 1471-2318
DOI: https://doi.org/10.1186/s12877-022-03547-w

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2022

Novel physical performance-based models for activities of daily living disability prediction among Chinese older community population: a nationally representative survey in China

Explanatory role of sociodemographic, clinical, behavioral, and social factors on cognitive decline in older adults with diabetes

Impact of prenatal and childhood adversity effects around World War II on multimorbidity: results from the KORA-Age study

Internet use and physical activity of older adults during the COVID-19 pandemic: a cross-sectional study in a northern Japanese City

Performance of the SarQoL quality of life tool in a UK population of older people with probable sarcopenia and implications for use in clinical trials: findings from the SarcNet registry

The role of depression and physical activity in the association of between sleep quality, and duration with and health-related quality of life among the elderly: a UK Biobank cross-sectional study

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials